The influence of thinness and smoking on bone loss and response to hormone replacement therapy in early postmenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 2, 2000, Pages 590-596

  Bjarnason, N H ^a   Christiansen, C ^a  

^a CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; BONE ATROPHY; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; OSTEOLYSIS; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

EID: 0034453807     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.85.2.6364     Document Type: Article

References (21)

1. Who are candidates for prevention and treatment for osteoporosis?
2. Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women
3. Premenopausal and postmenopausal changes in bone mineral density of the proximal femur measured by dual-energy x-ray absorptiometry
4. Vertebral postmenopausal bone loss is reduced in overweight women: A longitudinal study in 155 early postmenopausal women
5. Bone mass and body composition in normal women
6. Determinants of bone density in normal women: Risk factors for futures osteoporosis?
7. Influence of soft tissue body composition on bone mass and metabolism
8. Obesity and postmenopausal bone loss: The influence of obesity on vertebral density and bone turnover in postmenopausal women
9. Prediction of rapid bone loss in postmenopausal women
10. Onset of adolescent eating disorders: Population based cohort study over 3 years
11. Smoking, smoking cessation and risk of hip fracture in women
12. Cigarette smoking, serum estrogens and bone loss during hormone replacement therapy early after menopause
13. Low dose estradiol in combination with gestodeue is fully preventive on early postmenopausal bone loss
14. Applications of an enzyme immuno assay for a new markers of bone resorption (CrossLaps): Follow-up on hormone replacement therapy and osteoporosis risk assessment
15. Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen
16. Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies
17. Risk factors for hip fracture in white women
18. Bone loss associated with a high fibre diet reduction diet in postmenopausal women
19. Is cigarette smoking a promotor of the menopause?
20. Cigarette smoking, obesity, and bone mass
21. Smoking increases bone loss and decreases intestinal calcium absorption